Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gibble

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Journal of Crohn'S & Colitis|June 13, 2024
Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT ProgrammeSilvio Danese, Axel Dignass, Katsuyoshi Matsuoka, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|April 7, 2012
Progress in atomic fountains at LNE-SYRTEJocelyne Guéna, Michel Abgrall, Daniele Rovera, et al.
Crohn'S & Colitis 360|November 30, 2023
Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance StudiesBruce E Sands, Brian G Feagan, Theresa Hunter Gibble, et al.
The Journal of Infectious Diseases|April 7, 1999
Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virusD Tan, A Matsumoto, C Conry-Cantilena, et al.
Transfusion|November 9, 2011
Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALISuzanne A Arinsburg, Donna L Skerrett, Julie K Karp, et al.
Blood|August 30, 2008
Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infectionMelissa T Bartman, Zhanna Kaidarova, Dale Hirschkorn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 1, 2010
Increased all-cause and cancer mortality in HTLV-II infectionHope H Biswas, Zhanna Kaidarova, George Garratty, et al.
The Journal of Organic Chemistry|April 17, 2001
Boundary conditions on the partitioning of deaminatively generated benzyl cationsR W Darbeau, D J Heurtin, L M Siso, et al.
Seminars in Arthritis and Rheumatism|July 11, 2025
Discriminating capacity of the ASAS health index in patients with axial spondyloarthritis treated with ixekizumabUta Kiltz, Anna Moltó, Désirée van der Heijde, et al.
Inflammatory Bowel Diseases|August 21, 2023
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative ColitisSimon Travis, Alison Potts Bleakman, Marla C Dubinsky, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Journal of Crohn'S & Colitis|June 13, 2024
Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT ProgrammeSilvio Danese, Axel Dignass, Katsuyoshi Matsuoka, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|April 7, 2012
Progress in atomic fountains at LNE-SYRTEJocelyne Guéna, Michel Abgrall, Daniele Rovera, et al.
Crohn'S & Colitis 360|November 30, 2023
Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance StudiesBruce E Sands, Brian G Feagan, Theresa Hunter Gibble, et al.
The Journal of Infectious Diseases|April 7, 1999
Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virusD Tan, A Matsumoto, C Conry-Cantilena, et al.
Transfusion|November 9, 2011
Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALISuzanne A Arinsburg, Donna L Skerrett, Julie K Karp, et al.
Blood|August 30, 2008
Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infectionMelissa T Bartman, Zhanna Kaidarova, Dale Hirschkorn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 1, 2010
Increased all-cause and cancer mortality in HTLV-II infectionHope H Biswas, Zhanna Kaidarova, George Garratty, et al.
The Journal of Organic Chemistry|April 17, 2001
Boundary conditions on the partitioning of deaminatively generated benzyl cationsR W Darbeau, D J Heurtin, L M Siso, et al.
Seminars in Arthritis and Rheumatism|July 11, 2025
Discriminating capacity of the ASAS health index in patients with axial spondyloarthritis treated with ixekizumabUta Kiltz, Anna Moltó, Désirée van der Heijde, et al.
Inflammatory Bowel Diseases|August 21, 2023
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative ColitisSimon Travis, Alison Potts Bleakman, Marla C Dubinsky, et al.
Pageof 13